- 1. G Alpha Interacting Protein
- [Expressed most in lung, placenta, liver, and heart by human RGS19 Gene (RGS Family), membrane-bound fatty acylated 217-aa 25-kDa Regulator of G-protein Signaling 19 is a guanosine triphosphatase-activating protein, containing 1 RGS domain, that specifically interacts with G protein GAI3 and down-regulates G Alpha i/G Alpha q-linked signaling. Heavily palmitoylated in the Cys string motif and mainly phosphorylated on Ser residues, RGS19 inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits, driving them into the inactive GDP-bound form. RGS19 binds to G-Alpha subfamily 1 members and interacts with GIPC PDZ domain. (NCI) ( NCI )] (UMLS (NCI) C0384780) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 39. Gallbladder Cancer, Localized
- [Cancer found only in the tissues that make up the wall of the gallbladder. Localized gallbladder cancer can be removed completely in an operation. ( NCI )] (UMLS (NCI) C0877355) Localized Cancer of Gallbladder;
Localized Cancer of the Gallbladder;
localized gallbladder cancer;
Localized Gallbladder Carcinoma;
=Neoplastic Process |
- 2. GAL-8
- [Constitutively and ubiquitously expressed by human LGALS8 Gene (S-Lectin Family), 316-amino acid 35.5-kD extracellular Galectin 8 contains two carbohydrate-binding (recognition) domains (CRDs) and binds to beta galactoside in cell adhesion, cell cycle regulation, inflammation, immunomodulation, apoptosis, and metastasis. Galectin 8 may be involved in activation of various cell types through cross-linkage of cell surface glycoproteins and may be involved in some types of cancer. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C1098710) Galectin 8;
Lectin, Galactoside-Binding, Soluble, 8;
LGALS8;
LGALS8 Protein;
PCTA1;
Po66 Carbohydrate Binding Protein;
PO66 Carbohydrate-Binding Protein;
PO66-CBP;
Prostate Carcinoma Tumor Antigen;
Prostate Carcinoma Tumor Antigen 1 =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 40. Gallbladder Cancer, Recurrent
- [The reemergence of gall bladder cancer after a period of remission. ( NCI )] (UMLS (NCI) C0877357) Recurrent Cancer of Gallbladder;
Recurrent Cancer of the Gallbladder;
Recurrent Gallbladder Cancer;
Recurrent Gallbladder Carcinoma;
Relapsed Cancer of Gallbladder;
Relapsed Cancer of the Gallbladder;
Relapsed Gallbladder Cancer =Neoplastic Process |
- 3. galactan
- [polymers composed of galactose residues and occurring in plants, for example, agar. ( CSP )] (UMLS (CSP) C0016932) =Carbohydrate ;
=glycan;
hexosan =carrageenan;
Agar;
guar gum | - 41. Gallbladder Epithelium
- (UMLS (NCI) C1180206) =Tissue ;
|
- 4. galactitol
- [A naturally occurring product of plants obtained following reduction of GALACTOSE. It appears as a white crystalline powder with a slight sweet taste. It may form in excess in the lens of the eye in GALACTOSEMIAS, a deficiency of GALACTOKINASE. ( MSH )] (UMLS (CSP) C0013283) =Carbohydrate; Biologically Active Substance ;
| - 42. Gallbladder Fundus
- (UMLS (NCI) C0227544) =Body Part, Organ, or Organ Component
|
- 5. GALACTOCELE
- (UMLS (ICD9CM) C0152243) =Acquired Abnormality; Disease or Syndrome
| - 43. Gallbladder Hyperplastic Polyp
- (UMLS (NCI) C1333743) Hyperplastic Polyp of Gallbladder;
Hyperplastic Polyp of the Gallbladder =Disease or Syndrome ;
|
- 6. galactokinase
- [An enzyme that catalyzes reversibly the formation of galactose 1-phosphate and ADP from ATP and D-galactose. Galactosamine can also act as the acceptor. A deficiency of this enzyme results in GALACTOSEMIA. EC 2.7.1.6. ( MSH )] (UMLS (CSP) C0016937) =Amino Acid, Peptide, or Protein; Enzyme =alcohol phosphotransferase;
| - 44. Gallbladder Injury
- (UMLS (NCI) C0434028) =Injury or Poisoning
|
- 7. galactolipid
- [group of glycolipids in which the sugar group is galactose; distinguished from glycosphingolipids in lacking nitrogen; constitute the majority of membrane lipids in plants. ( CSP )] (UMLS (CSP) C0596591) =Lipid =glycolipid;
| - 45. Gallbladder Kaposi Sarcoma
- [A Kaposi sarcoma arising from the gallbladder. ( NCI )] (UMLS (NCI) C1333744) Gallbladder Kaposi's Sarcoma;
Kaposi's Sarcoma of Gallbladder;
Kaposi's Sarcoma of the Gallbladder;
=Neoplastic Process ;
|
- 8. galactorrhea
- [ ] (UMLS (CSP) C0269995) =Disease or Syndrome
| - 46. Gallbladder Leiomyoma
- [A benign smooth muscle neoplasm arising from the gallbladder. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. ( NCI )] (UMLS (NCI) C1333745) Leiomyoma of Gallbladder;
Leiomyoma of the Gallbladder =Neoplastic Process ;
|
- 9. Galactorrhea, antepartum condition or complication
- [ ] (UMLS (ICD9CM) C0157667) =Disease or Syndrome
| - 47. Gallbladder Leiomyosarcoma
- [An aggressive malignant smooth muscle neoplasm, arising from the gallbladder. It is characterized by a proliferation of neoplastic spindle cells. ( NCI )] (UMLS (NCI) C1333746) Leiomyosarcoma of Gallbladder;
Leiomyosarcoma of the Gallbladder =Neoplastic Process ;
|
- 10. Galactorrhea, postpartum condition or complication
- [ ] (UMLS (ICD9CM) C0157668) =Disease or Syndrome
| - 48. Gallbladder Lipoma
- [A benign adipose tissue neoplasm involving the gallbladder wall. ( NCI )] (UMLS (NCI) C1333747) Lipoma of Gallbladder;
Lipoma of the Gallbladder =Neoplastic Process ;
|
- 11. Galactorrhea, with delivery, with mention of postpartum complication
- [ ] (UMLS (ICD9CM) C0157666) =Disease or Syndrome
| - 49. Gallbladder Lymphoma
- (UMLS (NCI) C1333748) Lymphoma of Gallbladder;
Lymphoma of the Gallbladder;
Primary Gallbladder Lymphoma;
=Neoplastic Process ;
|
- 12. Galactorrhea, with delivery, with or without mention of antepartum condition
- [ ] (UMLS (ICD9CM) C0157665) =Disease or Syndrome
| - 50. Gallbladder Malignant Melanoma
- (UMLS (NCI) C1333749) Gallbladder Melanoma;
Malignant Melanoma of Gallbladder;
Malignant Melanoma of the Gallbladder;
Melanoma of Gallbladder;
Melanoma of the Gallbladder;
=Neoplastic Process ;
|
- 13. galactosamine
- [amino sugar derivative of galactose, substituted at the 2 position; occurs in a variety of glycosaminoglycans and complex polysaccharides, such as blood group substances, and is generally acetylated. ( CSP )] (UMLS (CSP) C0016943) =Carbohydrate; Biologically Active Substance =Hexosamines;
| - 51. Gallbladder Neck
- (UMLS (NCI) C0227546) =Body Part, Organ, or Organ Component
|
- 14. galactose
- [aldohexose that occurs naturally in the D-form in lactose, cerebrosides, gangliosides, and mucoproteins. ( CSP )] (UMLS (CSP) C0016945) =Carbohydrate; Indicator, Reagent, or Diagnostic Aid =hexose;
Inactive Ingredient Preparations =LACTULOSE 10 GM;
LACTULOSE 20 GM/PACKET Oral (systemic) powder for suspension;
GALACTOSE >2.2 GM/15ML;
Galactose 147 MG/ML;
| - 52. Gallbladder Neoplasm
- [Abnormal growth of the cells that comprise the gall bladder. ( NCI )] (UMLS (NCI) C0016978) =Neoplastic Process ;
=Biliary Neoplasm;
Unspecified disorder of gallbladder |
- 15. galactose 1 phosphate uridylyl transferase deficiency
- [ ] (UMLS (CSP) C0268151) =Disease or Syndrome ;
| - 53. Gallbladder Neurofibroma
- [A non-metastasizing encapsulated neoplasm arising from nerves in the gallbladder. Morphologically, it is characterized by the presence of fibroblasts and schwann cells. ( NCI )] (UMLS (NCI) C1333751) Neurofibroma of Gallbladder;
Neurofibroma of the Gallbladder =Neoplastic Process ;
|
- 16. galactose 1 phosphate uridylyltransferase
- [An enzyme that catalyzes the synthesis of UDPgalactose from UTP and galactose-1-phosphate. It is present in low levels in fetal and infant liver, but increases with age, thereby enabling galactosemic infants who survive to develop the capacity to metabolize galactose. EC 2.7.7.10. ( MSH )] (UMLS (CSP) C0016953) =Amino Acid, Peptide, or Protein; Enzyme
| - 54. Gallbladder Oat Cell Carcinoma
- (UMLS (NCI) C1333759) Gallbladder Small Cell Carcinoma;
Oat Cell Carcinoma of Gallbladder;
Oat Cell Carcinoma of the Gallbladder;
Small Cell Carcinoma of Gallbladder;
Small Cell Carcinoma of the Gallbladder;
=Neoplastic Process |
- 17. Galactose Metabolism
- [The chemical reactions and pathways involving galactose, the aldohexose galacto-hexose. D-galactose is widely distributed in combined form in plants, animals and microorganisms as a constituent of oligo- and polysaccharides; it also occurs in galactolipids and as its glucoside in lactose and melibiose. [ISBN:0198506732 "Oxford Dictionary of Biochemistry and Molecular Biology"] ( GO )] (UMLS (NCI) C1156458) Galactose Metabolism Pathway;
=Molecular Function | - 55. Gallbladder Pancreatic Heterotopia
- (UMLS (NCI) C1333752) =Finding ;
|
- 18. galactose oxidase
- [An enzyme that oxidizes galactose in the presence of molecular oxygen to D-galacto-hexodialdose. It is a copper protein. EC 1.1.3.9. ( MSH )] (UMLS (CSP) C0016948) =Amino Acid, Peptide, or Protein; Enzyme =alcohol oxidoreductase;
| - 56. Gallbladder Papillary Adenocarcinoma
- (UMLS (NCI) C1333753) Papillary Carcinoma of Gallbladder;
Papillary Carcinoma of the Gallbladder =Neoplastic Process |
- 19. galactosemia
- [group of inherited enzyme deficiencies which feature elevations of galactose in the blood; this condition may be associated with deficiencies of galactokinase, UDP glucose-hexose-1-phosphate uridylyltransferase (classic form), or UDP glucose 4-epimerase; the classic form presents in infancy with failure to thrive, vomiting, and intracranial hypertension; affected individuals also may develop mental retardation, jaundice, hepatosplenomegaly, ovarian failure and cataracts. ( CSP )] (UMLS (CSP) C0016952) =Disease or Syndrome ;
=Carbohydrate Metabolism, Inborn Errors;
enzyme deficiency;
Brain Diseases, Metabolic, Inborn;
| - 57. Gallbladder Papillomatosis
- (UMLS (NCI) C1333754) =Neoplastic Process
|
- 20. galactoside
- [glycosides formed by the reaction of the hydroxyl group on the anomeric carbon atom of galactose with an alcohol to form an acetal. ( CSP )] (UMLS (CSP) C0016956) =Carbohydrate ;
=Glycoside;
| - 58. Gallbladder Pleomorphic Spindle and Giant Cell Adenocarcinoma
- (UMLS (NCI) C1333755) Pleomorphic Spindle and Giant Cell Adenocarcinoma of Gallbladder;
Pleomorphic Spindle and Giant Cell Adenocarcinoma of the Gallbladder =Neoplastic Process |
- 21. Galactosyltransferase
- [nonEC. ( CSP )] (UMLS (NCI) C0016964) =Amino Acid, Peptide, or Protein; Enzyme =hexosyltransferase;
| - 59. Gallbladder Polyp
- (UMLS (NCI) C0262493) =Neoplastic Process
|
- 22. galanin
- [widely distributed in the central and peripheral nervous systems; modulates pituitary, pancreatic, and gastric hormone secretions; functional antagonist of cholinergic neurotransmission. ( CSP )] (UMLS (CSP) C0060993) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=neuropeptide;
| - 60. Gallbladder Rhabdomyosarcoma
- [A malignant mesenchymal tumor with skeletal muscle differentiation affecting the gallbladder. ( NCI )] (UMLS (NCI) C1333756) Rhabdomyosarcoma of Gallbladder;
Rhabdomyosarcoma of the Gallbladder =Neoplastic Process |
- 23. Galanin Receptor 2
- [Galanin Receptor 2 (GALR2) is encoded by the GALR2 gene. Galanin is an important neuromodulator, a 30-amino acid non-C-terminally amidated peptide that potently stimulates growth hormone secretion, inhibits cardiac vagal slowing of heart rate, abolishes sinus arrhythmia, and inhibits postprandial gastrointestinal motility. The actions of galanin are mediated through interaction with specific G protein-coupled receptors. GALR2 interacts with the N-terminal residues of the galanin peptide. Galanin Receptor 2 decreases cAMP through an inhibitory G-protein and stimulates phospholipase C and mobilizes calcium through Gq/G11. The primary signaling mechanism for GALR2 is through the phospholipase C/protein kinase C pathway (via Gq). (From LocusLink and NCI) ( NCI )] (UMLS (NCI) C0630195) =Amino Acid, Peptide, or Protein; Receptor
| - 61. Gallbladder Sarcoma
- (UMLS (NCI) C1333757) Sarcoma of Gallbladder;
Sarcoma of the Gallbladder =Neoplastic Process |
- 24. Galanin Receptor 2 Gene
- [This gene plays a role in cellular signal transduction through the phospholipase C/protein kinase C pathway. ( NCI )] (UMLS (NCI) C1333658) GALR2;
GALR2 Gene;
=Gene or Genome ;
| - 62. Gallbladder Signet Ring Cell Carcinoma
- (UMLS (NCI) C1333758) Signet Ring Cell Carcinoma of Gallbladder;
Signet Ring Cell Carcinoma of the Gallbladder =Neoplastic Process |
- 25. Galectin 3 Binding Protein
- [Widely expressed and encoded by human LGALS3BP Gene (MSR1 Superfamily), 585-amino acid extracellular Galectin 3 Binding Protein contains an N-terminal MSR1 Cys-rich domain and binds LGALS3 via carbohydrate-specific interaction. MAC2BP is a potent stimulator of host immune defense systems, such as NK and LAK cell cytotoxicity, and can induce IL2 cytokine production. Oncogenic transformation, viral infection, or pathogen invasion enhance MAC2BP production. LGALS3BP is elevated in the serum of cancer and HIV patients. (from LocusLink, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0217525) =Amino Acid, Peptide, or Protein; Immunologic Factor; Indicator, Reagent, or Diagnostic Aid
| - 63. Gallego
- (UMLS (HL7) C1553364) =Population Group =Spaniard;
|
- 26. Galena Village (aka Louden Village)
- (UMLS (HL7) C1550861) =Population Group =NativeEntityAlaska;
| - 64. Gallium nitrate
- [A drug that lowers blood calcium. Used as treatment for hypercalcemia (too much calcium in the blood) and for cancer that has spread to the bone (bone metastases). ( NCI )] (UMLS (NCI) C0061008) =Pharmacologic Substance; Inorganic Chemical ;
=Ga;
[HS900] HORMONES/SYNTHETICS/MODIFIERS, OTHER =GALLIUM NITRATE 25 MG/ML;
|
- 27. Gall Bladder
- [storage reservoir for bile secretion; allows the delivery of bile acids at a high concentration and in a controlled manner, via the cystic duct to the duodenum, for degradation of dietary lipid. ( CSP )] (UMLS (HL7) C0016976) =Body Part, Organ, or Organ Component ;
=Bile Tract;
Body Part | - 65. Gallium Nitrate/Hydroxyurea
- (UMLS (NCI) C0281535) =Therapeutic or Preventive Procedure
|
- 28. GALLAMINE TRIETHIODIDE
- [synthetic nondepolarizing blocking drug. ( CSP )] (UMLS (NCI) C0016972) =Organic Chemical; Pharmacologic Substance =ammonium compound;
GALLAMINE;
[MS300] NEUROMUSCULAR BLOCKING AGENTS;
quaternary ammonium compound;
phenylalkoxyalkylamine;
| - 66. Gallium Nitrate/Ifosfamide/Vinblastine
- (UMLS (NCI) C0281471) =Therapeutic or Preventive Procedure
|
- 29. GALLBLADDER ANASTOM NEC
- [ ] (UMLS (ICD9CM) C0176904) =Therapeutic or Preventive Procedure
| - 67. Gallium Nitrate/Paclitaxel
- (UMLS (NCI) C0281635) =Therapeutic or Preventive Procedure
|
- 30. Gallbladder Body
- (UMLS (NCI) C0227545) =Body Part, Organ, or Organ Component
| - 68. Gallium Scan
- [A nuclear imaging procedure in which gallium-67 is used as the radiopharmaceutical. Gallium binds to transferrin, leukocyte lactoferrin, bacterial siderophores and inflammatory proteins and thereby can be used to localize foci of infection. It is also taken up by several tumors, thus gallium scintigraphy can be used for the staging of tumors. ( NCI )] (UMLS (NCI) C0521316) =Diagnostic Procedure
|
- 31. gallbladder cancer
- [Primary or metastatic malignant neoplasm of the gallbladder. ( NCI )] (UMLS (CSP) C0153452) =Neoplastic Process
| - 69. gallon (Queen Anne's wine gallon)
- [231 [in_i]3 ( HL7V3.0 )] (UMLS (HL7) C1552932) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens |
- 32. Gallbladder Cancer Stage I
- [Stage I includes: IA: (T1, N0, M0); IB: (T2, N0, M0). T1: Tumor invades lamina propria or muscle layer. T1a: Tumor invades lamina propria. T1b: Tumor invades muscle layer. N0: No regional metastasis. M0: No distant metastasis. (AJCC 6th ed.) - 2003 ( NCI )] (UMLS (NCI) C1167716) Gallbladder Carcinoma Stage I;
Stage I Carcinoma of Gallbladder;
Stage I Carcinoma of the Gallbladder;
Stage I Gallbladder Cancer;
Stage I Gallbladder Carcinoma =Neoplastic Process | - 70. GALLSTONE ILEUS
- [ ] (UMLS (ICD9CM) C0156156) =Disease or Syndrome ;
|
- 33. Gallbladder Cancer Stage II
- [Stage II includes: IIA: (T3, N0, M0); IIB: (T1, N0, M0); (T2, N0, M0); (T3, N0, M0). T2: Tumor perforates the serosa (visceral peritoneum) and/or directly invades the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, or pancreas, omentum or extrahepatic bile ducts. (AJCC 6th ed.) - 2003 ( NCI )] (UMLS (NCI) C1142296) Gallbladder Carcinoma Stage II;
Stage II Carcinoma of Gallbladder;
Stage II Carcinoma of the Gallbladder;
Stage II Gallbladder Cancer;
Stage II Gallbladder Carcinoma =Neoplastic Process | - 71. GalNAc(beta 1->4)-[NeuAc(alpha 2->8)NeuAc(alpha 2->3)]Gal(beta 1->4)GlcCer
- [A cell surface antigen expressed on all tumors of neuroectodermal origin, including melanoma, neuroblastomas, sarcoma, astrocytomas, and small cell lung cancer. GD2 is an O-acetylated disialoganglioside, belongs to the group of glycosphingolipids that are widely expressed in many tissues and organs in vertebrates and have been suggested to be involved in the regulation of development and differentiation as recognition molecules or signal modulators. Due to its high level of expression in neuroblastoma, GD2 has potential to be used as a component of anti-neuroblastoma vaccines, in addition to be used in polyvalent anti-melanoma vaccines ( NCI )] (UMLS (NCI) C0061104) =Lipid
|
- 34. Gallbladder Cancer Stage III
- [Stage III includes: (T4, Any N, M0). T4: Tumor invades main portal vein or hepatic artery or invades multiple extrahepatic organs or structures. (AJCC 6th ed.) - 2003 ( NCI )] (UMLS (NCI) C1141952) Gallbladder Carcinoma Stage III;
Stage III Carcinoma of Gallbladder;
Stage III Carcinoma of the Gallbladder;
Stage III Gallbladder Cancer;
Stage III Gallbladder Carcinoma =Neoplastic Process | - 72. GALT
- [Non-encapsulated accumulations of lymphoid tissue in the alimentary tract that form a secretory immune system containing cells committed to IgA or IgE synthesis; It includes Peyer's patches and the lymphoid tissue which is present throughout the gastrointestinal mucosa. ( NCI )] (UMLS (NCI) C0596638) =Tissue ;
=secretory immune system;
=Peyer's Patch;
|
- 35. Gallbladder Cancer Stage IV
- [Stage IV includes: (Any T, Any N, M1). M1: Distant metastasis. (AJCC 6th ed.) - 2003 ( NCI )] (UMLS (NCI) C1141953) Gallbladder Carcinoma Stage IV;
Stage IV Carcinoma of Gallbladder;
Stage IV Carcinoma of the Gallbladder;
Stage IV Gallbladder Cancer;
Stage IV Gallbladder Carcinoma =Neoplastic Process | - 73. galvanometry
- [ ] (UMLS (CSP) C0598235) =Laboratory Procedure ;
|
- 36. Gallbladder Cancer Stage IVA
- (UMLS (NCI) C1168199) Gallbladder Carcinoma Stage IVA;
Stage IVA Carcinoma of Gallbladder;
Stage IVA Carcinoma of the Gallbladder;
Stage IVA Gallbladder Cancer;
Stage IVA Gallbladder Carcinoma =Neoplastic Process | - 74. Galzin
- (UMLS (NCI) C0728966) =Organic Chemical; Pharmacologic Substance ;
|
- 37. Gallbladder Cancer Stage IVB
- (UMLS (NCI) C1168200) Gallbladder Carcinoma Stage IVB;
Stage IVB Carcinoma of Gallbladder;
Stage IVB Carcinoma of the Gallbladder;
Stage IVB Gallbladder Cancer;
Stage IVB Gallbladder Carcinoma =Neoplastic Process | - 75. [gal_us]
- [LITERAL ( NCI )] (UMLS (NCI) C0560013) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens |
- 38. Gallbladder Cancer Unresectable
- [Cancer that has spread to the tissues around the gallbladder (such as the liver, stomach, pancreas, intestine, or lymph nodes in the area) and cannot be surgically removed. ( NCI )] (UMLS (NCI) C0278807) =Neoplastic Process
| |
home
